drugset / Trial / NCT01929954

Safety Study of Gintuit™ in Subjects Requiring Socket Grafting

NCT01929954 ↗

Phase 1/2 Terminated 5 enrolled Organogenesis
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective, randomized, controlled, parallel group Phase 1/2 assessment of the safety of GINTUIT versus Bio-Gide in subjects who have a posterior tooth requiring extraction. The incidence and severity of adverse events will be summarized by group (GINTUIT and Bio-Gide).

Timeline

Start
2013-07
Primary completion
2015-03
Completion
2015-03

Outcome

Outcome not reported

Stopped (Business): “Changes in corporate business environment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Gintuit Unknown — —

Indications

No indication recorded.